Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma

Multiple myeloma (MM) is a very heterogeneous disease with multiple symptoms and clinical manifestations. MM affects mainly elderly patients and is difficult to manage in the presence of comorbidities, polypharmacy, frailty and adverse events of disease-targeted drugs. The rapid changes in MM treatm...

Full description

Bibliographic Details
Main Authors:	Catarina Geraldes, Adriana Roque, Ana Bela Sarmento-Ribeiro, Manuel Neves, Alina Ionita, Rita Gerivaz, Ana Tomé, Sofia Afonso, Maria Pedro Silveira, Patrícia Sousa, Rui Bergantim, Cristina João
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Oncology
Subjects:	delivery of health care cancer management anticancer drug toxicities multiple myeloma real life practical considerations myeloma-related manifestations
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1282300/full

Similar Items

Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies
by: Joana Jorge, et al.
Published: (2023-05-01)

P841: MOLECULAR MECHANISMS OF RESISTANCE TO IMMUNOMODULATORS IN MULTIPLE MYELOMA: AN IN VITRO STUDY
by: Raquel Alves, et al.
Published: (2023-08-01)

Gamapatias Monoclonais de Significado Indeterminado: Critérios de Diagnóstico e Acompanhamento Clínico
by: Joana Parreira, et al.
Published: (2014-09-01)

CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression
by: Cristiana Rodrigues, et al.
Published: (2024-03-01)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
by: Bergantim Rui, et al.
Published: (2012-11-01)

Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
by: Guimarães Cristina, et al.
Published: (2012-06-01)

Zinc: From Biological Functions to Therapeutic Potential
by: Maria Inês Costa, et al.
Published: (2023-03-01)

Multiple Myeloma: Available Therapies and Causes of Drug Resistance
by: Vanessa Pinto, et al.
Published: (2020-02-01)

Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo
by: Cristina João, et al.
Published: (2023-07-01)

Mandibular Swelling as the First Manifestation of Multiple Myeloma
by: Maryam Amirchaghmaghi, et al.
Published: (2010-12-01)

Orbital Plasmacytoma, An Uncommon Presentation of Advanced Multiple Myeloma
by: Andreia Margarida de Matos, et al.
Published: (2020-01-01)

Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma
by: Ana Codorniz, et al.
Published: (2017-09-01)

P1358: WILL COVID-19 PANDEMIC CHANGE MOBILIZATION STRATEGY OF HEMATOPOIETIC STEM CELLS IN MULTIPLE MYELOMA PATIENTS FOR THE BETTER?
by: B. Marques, et al.
Published: (2022-06-01)

Apoptosis and (in) Pain—Potential Clinical Implications
by: Hugo Ribeiro, et al.
Published: (2022-05-01)

Oral health status of patients with multiple myeloma
by: Édila Figuerêdo Feitosa, et al.
Published: (2020-04-01)

A unique rhinologic manifestation of multiple myeloma
by: Jun Jie Seah, et al.
Published: (2021-06-01)

Combination of Elacridar with Imatinib Modulates Resistance Associated with Drug Efflux Transporters in Chronic Myeloid Leukemia
by: Raquel Alves, et al.
Published: (2022-05-01)

PB1841: NUCLEOLIN INTERACTS WITH NUCLEOPHOSMIN AS A PREDICTOR OF PROGNOSIS IN ACUTE MYELOBLASTIC LEUKEMIA
by: Marta Pereira, et al.
Published: (2023-08-01)

Oxidative Stress Parameters Can Predict the Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndrome Patients
by: Ana Cristina Gonçalves, et al.
Published: (2021-06-01)

Modelos experimentais em oncologia: O contributo da cultura de células para o conhecimento da biologia do cancro Experimental models in oncology: Contribution of cell culture on understanding the biology of cancer
by: Mariana Cruz, et al.
Published: (2009-08-01)

Cold Atmospheric Plasma Apoptotic and Oxidative Effects on MCF7 and HCC1806 Human Breast Cancer Cells
by: Catarina Almeida-Ferreira, et al.
Published: (2022-02-01)

Antitumor Effect of Brusatol in Acute Lymphoblastic Leukemia Models Is Triggered by Reactive Oxygen Species Accumulation
by: Joana Jorge, et al.
Published: (2022-09-01)

Hematological changes in SARS-COV-2 positive patients
by: Mafalda Urbano, et al.
Published: (2022-04-01)

PB2153: IMPACT OF EXTRAMEDULLARY DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: MULTICENTER RETROSPECTIVE ANALYSIS
by: Rita Costa e Sousa, et al.
Published: (2023-08-01)

An Oral Plasmacytoid Mass: The Result of a Malcontrolled Multiple Myeloma
by: Narges Mirjalili, et al.
Published: (2010-12-01)

An Oral Plasmacytoid Mass: The Result of a Malcontrolled Multiple Myeloma
by: Narges Mirjalili, et al.
Published: (2010-10-01)

PB1822: INHIBITION OF THE DNA DAMAGE RESPONSE: A POSSIBLE NEW ROUTE IN ACUTE MYELOBLASTIC LEUKEMIA TREATMENT
by: Beatriz Lapa, et al.
Published: (2023-08-01)

UJI AKTIVITAS ANTIKANKER EKSTRAK ETANOL DAUN Rhizopora mucronata TERHADAP SEL MYELOMA
by: Hartiwi Diastuti, et al.
Published: (2008-11-01)

Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept
by: Rui Bergantim, et al.
Published: (2022-11-01)

Case for diagnosis
by: Guida Santos, et al.
Published: (2014-01-01)

Modelos experimentais em oncologia: O contributo da cultura de cÃ©lulas para o conhecimento da biologia do cancro
by: Mariana Cruz, et al.
Published: (2009-07-01)

Anaplastic morphology in IgD multiple myeloma
by: Verónica Roldán Galiacho, et al.
Published: (2023-10-01)

Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring
by: Ivana Martins, et al.
Published: (2021-02-01)

PB1719: NIRAPARIB IN B-CELL LYMPHOID MALIGNANCIES: EXPLORING SYNTHETIC LETHALITY AS TARGET FOR THERAPY
by: Beatriz Lapa, et al.
Published: (2023-08-01)

P659: BUPARLISIB A PROMISING THERAPEUTIC APPROACH IN CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB
by: Raquel Alves, et al.
Published: (2023-08-01)

<i>Enterococcus</i> Virulence and Resistant Traits Associated with Its Permanence in the Hospital Environment
by: Catarina Geraldes, et al.
Published: (2022-06-01)

Central Autonomic Network Regions and Hypertension: Unveiling Sympathetic Activation and Genetic Therapeutic Perspectives
by: Vera Geraldes, et al.
Published: (2023-08-01)

High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
by: Maryam Pourabdollah, et al.
Published: (2016-11-01)

Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia—A Pilot Study
by: Hugo Ribeiro, et al.
Published: (2023-06-01)

Platelet Membrane Proteins as Pain Biomarkers in Patients with Severe Dementia
by: Hugo Ribeiro, et al.
Published: (2023-01-01)